Jefferies

Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by…

If pharmaceutical drug patents are an hourglass turned over on the day of approval – with the approaching loss of…

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…

E-commerce giant Alibaba Group Holding has won “consumer mindshare” amid its instant commerce push, according to company executives and analysts,…

China’s cost and efficiency advantages in drug development have been recognised at the world’s largest cancer research conference in the…

Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…

And with additional headwinds expected in 2025, they said, brands with international appeal or unique selling points are driving new…